Galeazzi R L, Omar-Amberg C, Karlaganis G
Clin Pharmacol Ther. 1981 Apr;29(4):440-6. doi: 10.1038/clpt.1981.61.
Plasma and saliva N-acetyl-procainamide (NAPA) concentrations were measured by high-power liquid chromatography (HPLC) after intravenous infusion of 750 mg to 14 elderly patients (x age = 69 yr). The plasma NAPA disappearance curve can best be described by a two-compartment body model. Mean total body clearance was 10.6 1/hr, Vdss 125.8 1, and terminal half-life (t 1/2) 8.8 hr. A nonrenal clearance of 2.72 1/hr was calculated, that is, 19% of the expected total body clearance with normal kidney function. Saliva concentrations show huge inter- and intraindividual variability and are probably not usable for NAPA monitoring in older patients.
对14名老年患者(平均年龄69岁)静脉输注750毫克后,采用高效液相色谱法(HPLC)测定血浆和唾液中N - 乙酰普鲁卡因胺(NAPA)的浓度。血浆NAPA消除曲线最适合用二室模型来描述。平均总体清除率为10.6升/小时,稳态分布容积为125.8升,终末半衰期(t1/2)为8.8小时。计算得出非肾清除率为2.72升/小时,即正常肾功能预期总体清除率的19%。唾液浓度在个体间和个体内存在巨大差异,可能不适用于老年患者的NAPA监测。